Twist Bioscience Reports Strong Q2 2025 Financial Results and Business Highlights
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results South San Francisco, California—(Business Wire)—Twist Bioscience Corporation (NASDAQ: TWST), a leading mid-cap growth and value equity company in the life sciences sector, has released its financial results and business highlights for the second quarter of fiscal 2025, which ended on March 31, 2025. For a comprehensive overview of the earnings report and the investor presentation, visit the "Events and Presentations" page in the Investor Relations section of the company's website at www.twistbioscience.com, or access it directly through this link: https://investors.twistbioscience.com/events-and-presentations. Twist Bioscience will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today. The call will be broadcast live via the Investor Relations section of the company’s website. Participants who wish to join by phone should register on the Investor Relations website or via the provided link. Upon registration, phone participants will receive a dial-in number and a unique PIN to access the call. To ensure timely participation, we recommend dialing in at least fifteen minutes before the scheduled start time. A webcast replay will be available for two weeks following the event. About Twist Bioscience Corporation Twist Bioscience is dedicated to supporting customers who are making significant positive impacts across various sectors, including medicine, agriculture, industrial chemicals, and defense. By leveraging our advanced synthetic DNA tools, these customers are developing innovative solutions to enhance human lives and promote environmental sustainability. The faster our customers achieve their goals, the sooner the benefits extend to everyone. Twist Bioscience is uniquely positioned to help them accelerate progress. Our cutting-edge silicon-based DNA Synthesis Platform offers precision on a scale unmatched by traditional methods. This platform overcomes the inefficiencies associated with conventional techniques and enables cost-effective, rapid, and precise high-throughput synthesis, sequencing, and therapeutic discovery. We provide the quality and quantity of tools necessary for our customers to fully capitalize on the opportunities ahead. For more information about our products and services, visit www.twistbioscience.com. Stay connected with Twist Bioscience on social media: LinkedIn, X, YouTube, Instagram, and Bluesky. For additional updates and news from Twist Bioscience Corporation, please visit our website.